Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment – a real-life cohort study

OBJECTIVE: This study aims to analyse the effect of the discontinuation of anti-calcitonin gene-related peptide antibodies on monthly migraine days after 12 treatment months. BACKGROUND: Anti-calcitonin gene-related peptide antibodies have been a game changer in migraine prophylaxis. However, high t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gantenbein, Andreas R, Agosti, Reto, Gobbi, Claudio, Flügel, Dominique, Schankin, Christoph J, Viceic, Dragana, Zecca, Chiara, Pohl, Heiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504406/
https://www.ncbi.nlm.nih.gov/pubmed/34000847
http://dx.doi.org/10.1177/03331024211014616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504406/
https://www.ncbi.nlm.nih.gov/pubmed/34000847
http://dx.doi.org/10.1177/03331024211014616

Ejemplares similares